Search

Your search keyword '"Guo, Lixin"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Guo, Lixin" Remove constraint Author: "Guo, Lixin" Region china Remove constraint Region: china
48 results on '"Guo, Lixin"'

Search Results

2. Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.

3. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition).

4. Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real‐world setting: A prospective, observational post‐marketing study.

5. Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients.

6. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China.

7. A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE).

8. A new, alternative risk score for sarcopenia in Chinese patients with type 2 diabetes mellitus.

9. A Regional Ionospheric Storm Forecasting Method Using a Deep Learning Algorithm: LSTM.

10. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.

11. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.

12. Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open‐label, randomized controlled BEYOND‐V trial

13. Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN).

14. Application of new international classification of adult‐onset diabetes in Chinese inpatients with diabetes mellitus.

15. Changes in Direct Medical Cost and Medications for Managing Diabetes in Beijing, China, 2016 to 2018: Electronic Insurance Data Analysis.

16. Secular trends and rural-urban differences in endocrine and metabolic disease mortality in China: an age-period-cohort modeling of National Data.

17. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).

18. Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes—A multicenter cross-sectional observational study across China.

19. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study.

20. A comparative study of ionospheric spread-F and scintillation at low- and mid-latitudes in China during the 24th solar cycle.

21. Prediction of Chinese drivers' intentions to park illegally in emergency lanes: An application of the theory of planned behavior.

22. Uric acid, renal function and risk of hypoglycaemia in Chinese type 2 diabetes patients.

23. Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.

24. Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality.

25. Morphological and molecular characterization of free-floating and attached green macroalgae Ulva spp. in the Yellow Sea of China.

26. Prevalence of very high cardiovascular disease risk in patients with type 2 diabetes mellitus: A population‐based cross‐sectional screening study.

27. Standards of medical care for type 2 diabetes in China 2019.

28. Chinese clinical guidelines for continuous glucose monitoring (2018 edition).

29. Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China.

30. Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.

31. Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus.

32. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes: The EARLY Randomized Clinical Trial.

33. Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study.

34. Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016-2018.

35. Effect of foetal exposure to famine on the risk of nonalcoholic fatty liver disease in adulthood: A systematic review and meta-analysis.

36. Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study.

37. Application of novel subgroups of Chinese inpatients with diabetes based on machine learning paradigm.

39. Changes in Direct Medical Cost and Medications for Managing Diabetes in Beijing, China, 2016 to 2018: Electronic Insurance Data Analysis.

40. Glucose-lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology.

41. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.

42. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).

43. The relationship between human adenovirus 36 and obesity in Chinese Han population.

44. Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.

45. A Multicenter Evaluation of the Performance and Usability of a Novel Glucose Monitoring System in Chinese Adults With Diabetes.

46. Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.

47. China type 2 diabetes treatment status survey of treatment pattern of oral drugs users

48. Prevalence and associated factors of obstructive sleep apnea in hospitalized patients with type 2 diabetes in Beijing, China 2.

Catalog

Books, media, physical & digital resources